Back
Atossa Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
ATOS
Atossa Therapeutics, Inc.
Last Price:
$4.21
Seasonality Move:
3.3%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATOS is experiencing slight buying pressure.
Atossa Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.36 | Buy |
| 20-day SMA: | 6.44 | Sell |
| 50-day SMA: | 8.74 | Sell |
| 200-day SMA: | 11.77 | Sell |
| 8-day EMA: | 4.6 | Sell |
| 20-day EMA: | 5.95 | Sell |
| 50-day EMA: | 8.09 | Sell |
| 200-day EMA: | 11.31 | Sell |
Atossa Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.45 | Sell |
| Relative Strength Index (14 RSI): | 26 | Sell |
| Chaikin Money Flow: | 20124 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.61 - 9.29) | Sell |
| Bollinger Bands (100): | (7.86 - 14.12) | Sell |
Atossa Therapeutics, Inc. Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atossa Therapeutics, Inc. Stock
Is Atossa Therapeutics, Inc. Stock a Buy?
-
Atossa Therapeutics, Inc. share price is 4.42 while ATOS 8-day simple moving average is 4.36, which is a Buy signal.
-
The stock price of ATOS is 4.42 while Atossa Therapeutics, Inc. 20-day SMA is 6.44, which makes it a Sell.
-
Atossa Therapeutics, Inc. 50-day simple moving average is 8.74 while ATOS share price is 4.42, making it a Sell technically.
-
ATOS stock price is 4.42 and Atossa Therapeutics, Inc. 200-day simple moving average is 11.77, creating a Sell signal.
ATOS Technical Analysis vs Fundamental Analysis
Sell
26
Atossa Therapeutics, Inc. (ATOS)
is a Sell
Is Atossa Therapeutics, Inc. a Buy or a Sell?
-
Atossa Therapeutics, Inc. stock is rated a SellThe current Atossa Therapeutics, Inc. [ATOS] share price is $4.42. The Score for ATOS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Atossa Therapeutics, Inc. Stock Info
Market Cap:
38.1M
Price in USD:
4.42
Share Volume:
78.8K
Atossa Therapeutics, Inc. 52-Week Range
52-Week High:
19.35
52-Week Low:
3.76
Sell
26
Atossa Therapeutics, Inc. (ATOS)
is a Sell
Atossa Therapeutics, Inc. Share Price Forecast
-
What is the Atossa Therapeutics, Inc. stock price today?The Atossa Therapeutics, Inc. stock price is 4.42 USD today.
-
Will ATOS stock go up or go down?Atossa Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Atossa Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atossa Therapeutics, Inc. is overvalued.
Is Atossa Therapeutics, Inc. Stock a Buy?
-
Atossa Therapeutics, Inc. share price is 4.42 while ATOS 8-day exponential moving average is 4.60, which is a Sell signal.
-
The stock price of ATOS is 4.42 while Atossa Therapeutics, Inc. 20-day EMA is 5.95, which makes it a Sell.
-
Atossa Therapeutics, Inc. 50-day exponential moving average is 8.09 while ATOS share price is 4.42, making it a Sell technically.
-
ATOS stock price is 4.42 and Atossa Therapeutics, Inc. 200-day simple moving average is 11.31, creating a Sell signal.
Fundamental Analysis of Atossa Therapeutics, Inc.
Is Atossa Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.93 per share.
Technical Analysis of Atossa Therapeutics, Inc.
Should I short Atossa Therapeutics, Inc. stock?
-
ATOS Moving Average Covergence Divergence (MACD) indicator is -1.45, suggesting Atossa Therapeutics, Inc. is a Sell
-
Atossa Therapeutics, Inc. Relative Strength Index (RSI) is 26, which suggest Atossa Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Atossa Therapeutics, Inc. is (4.61 - 9.29), which suggest Atossa Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Atossa Therapeutics, Inc. is (7.86 - 14.12), which suggest Atossa Therapeutics, Inc. is a Sell
* Atossa Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.